TYBR Health Announces $30 Million Series A Financing to Expand Access to the B3 GEL® System
HOUSTON, July 21, 2026 /PRNewswire/ -- TYBR Health today announced a $30 million Series A financing led by Vensana Capital and Mutual Capital Partners, with participation from Neovate Capital Partners and existing investors. The company will use the funds to expand commercial access to...
HOUSTON, July 21, 2026 /PRNewswire/ -- TYBR Health today announced a $30 million Series A financing led by Vensana Capital and Mutual Capital Partners, with participation from Neovate Capital Partners and existing investors. The company will use the funds to expand commercial access to...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.